Further evaluation of the interaction between TNF and VEGF will be important to elucidate the mechanisms underlying these systemic pathways and understand the role of systemic biomarkers for earlier diagnosis and specific therapies for AMD. The gene discussed is VEGFA; the disease is age-related macular degeneration.